Decoding Johnson & Johnson (JNJ): A Strategic SWOT Insight
Unveiling the Financial and Strategic Landscape Post Q1 2024
Stay updated with breaking news from Pharmaceutical Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Unveiling the Financial and Strategic Landscape Post Q1 2024
An independent data monitoring committee concluded Bayer’s experimental drug for atrial fibrillation would not be more effective than Eliquis, a blockbuster product currently used for the indication. Consequently, Bayer decided to stop that Phase 3 test for the once-daily oral small molecule.
Bayer opens its new cell therapy manufacturing facility as it prepares a Parkinson’s disease cell therapy for Phase 2 testing. The new 100,000 square foot facility also has space for manufacturing other cell therapies in the pharma giant’s pipeline.
In the ever-evolving landscape of healthcare in the Philippines, one steadfast promise has endured— Generika Drugstore's unwavering commitment to its founding vision of empowering Filipinos to take better care of their health by providing access to quality, affordable medicines and other healthcare essentials. This is the Ginhawang Generika promise that seeded its founding in 2003
Generika Drugstore celebrates Dalawang Dekada ng Ginhawa with National Libreng Konsulta Day